“The VA/DoD CPG provides primary care clinicians with up-to-date practical recommendations for accurately staging CKD, predicting progression to kidney failure, and using pharmacotherapies to prevent ...
Angiotensin II receptor blockers (ARBs) are drugs that treat certain conditions affecting the heart and blood vessels as well as a kidney condition resulting from diabetes. People generally tolerate ...
Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...
The potential benefit of angiotensin II-receptor antagonism is not limited to well-tolerated blood pressure control. Angiotensin II has complex effects on the heart and kidneys. Blocking the effects ...
Receiving a cancer diagnosis during hospitalization and associations with care outcomes.
Renin–angiotensin system (RAS) inhibitors — including angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) — slow the progression of mild or moderate chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results